Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China
Featured articles
Articles
-
-
Targeting the glymphatic system: Aβ accumulation and phototherapy strategies across different stages of Alzheimer’s disease
-
Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer’s disease: associations with Aβ, tau, synaptic proteins and APOE ε4
-
Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases
-
Disarming COX-1 to disrupt Alzheimer’s inflammatory trajectory: preclinical insights and translational promise
-
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
-
Measles-mumps-rubella vaccination timing and autism among young african american boys: a reanalysis of CDC data
-
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States
-
Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
-
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Editor-in-Chief
Aims and Scope
Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.
Affiliated with
Annual Journal Metrics
-
Citation Impact
Journal Impact Factor: 15.2 (2024)
5-year Journal Impact Factor: 15.0 (2024)
Source Normalized Impact per Paper (SNIP): 2.190 (2024)
SCImago Journal Rank (SJR): 3.850 (2024)Speed
Submission to first editorial decision (median days): 7
Submission to acceptance (median days): 126Usage 2024
Downloads: 782,151
Altmetric mentions: 24,032